BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
search help

Documents 1-25 out of 47 found
  Current Search:  depacon: 55, valproate: 244  

100%
HTML
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Matching: depacon valproate Find similar documents More document info
100%
HTML
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Matching: depacon valproate Find similar documents More document info
100%
HTML
Valproic acid for epilepsy - [Medication] - Quest Diagnostics Patient Health Library
Valproic acid for epilepsy Examples Brand Name Chemical Name Depakene valproic acid Depakote, Depakote ER divalproex sodium Depacon valproate sodium These medications usually require several doses each day.
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About Valproic acid for epilepsy - [Medication] - Quest...
Matching: depacon valproate Find similar documents More document info
100%
HTML
Mood-stabilizing medications for bipolar disorder - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Mood-stabilizing medications for bipolar disorder - [Medication] - Quest Diagnostics Patient Health Library Mood-stabilizing medications for bipolar disorder - [Medication] - Quest Diagnostics Patient Health Library bipolar disease, Bipolar disorder,...
Matching: depacon valproate Find similar documents More document info
100%
HTML
Drug Approvals - D
Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted DMSA (Kit for the preparation of Tc99m Succimer for Injection), Rx Amersham Health NDA 17-944/S-018 11/24/03 11/25/03 - - Dacarbazine for Injection USP, 200 mg/vial, Rx Faulding Pharmaceutical Co
NDA 20-629/S-008 10/10/02 - 10/16/03 10/16/03 Depacon (Valproate Sodium) Injection,...
Matching: depacon valproate Find similar documents More document info
100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
45, DIHYDROERGOTAMINE MESYLATE DACARBAZINE, DACARBAZINE DALGAN, DEZOCINE DALMANE, FLURAZEPAM HYDROCHLORIDE DANAZOL, DANAZOL DANOCRINE, DANAZOL DANTRIUM, DANTROLENE SODIUM DAPSONE, DAPSONE DARANIDE, DICHLORPHENAMIDE DARAPRIM, PYRIMETHAMINE DARBID, ISOPROPAMIDE IODIDE DARICON, OXYPHENCYCLIMINE HYDROCHLORIDE DARVOCET A500, ACETAMINOPHEN DARVOCET, ACETAMINOPHEN DARVOCET-N 100,...

Matching: depacon valproate Find similar documents More document info
100%
HTML
Patent and Exclusivity Terms
TREATMENT UP TO 6 MONTHS WAS SHOWN EFFICACIOUS D-55 ADDITION OF A HIGHER DOSE OF NUTROPIN FOR PUBERTAL PATIENTS (PUBERTAL DOSE LESS THAN OR EQUAL TO 0.7MG/KG/WEEK) D-56 ADDITION OF POSTPRANDIAL DOSING D-57 3-HOUR INFUSION OF TAXOL GIVEN EVERY THREE WEEKS AT A DOSE OF 175MG/M2 FOLLOWED BY CISPLATIN AT A DOSE OF 75MG/M2 FOR THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN CANCER D-58...
Matching: depacon valproate Find similar documents More document info
100%
HTML
1998 Warning Letters and Untitled Letters to Pharmaceutical Companies
Searle DDMAC 5/26 8/3 Keri Anti-Bacterial Hand Lotion Bristol-Myers Squibb DLNDC 5/6 6/5 Naproxen Delayed Release Tablets Bristol-Myers Squibb DDMAC 5/26 8/3 Nasacort (Triamcinolone Acetonide) Rhone-Poulenc Rorer DDMAC 5/7 5/29 Pacerone (Amiodarone HCl) Tablets Upsher-Smith DDMAC 5/28 6/5 Pravachol (pravastatin sodium) Tablets Bristol-Myers Squibb DDMAC 5/1 6/16 Premarin (Conjugated...
Matching: depacon valproate Find similar documents More document info
100%
HTML
First-Time Generics - November 2002
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search First-Time Generics - November 2002 - Generic Drug Name Generic Manufacturer Brand Name Product Approval Date 1 OMEPRAZOLE DELAYED-RELEASE CAPSULES 10 MG, AND 20 MG KREMERS URBAN DEVELOPMENT COMPANY PRILOSEC DELAYED-RELEASE CAPSULES 11/1/02 2 AMCINONIDE LOTION 0.1% ALTANA INC author: OGD
Matching: depacon valproate Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 11/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;5MG N40478 001 NOV 08, 2002 NOV NEWA -A- AA 500MG;10MG N40473 001 NOV 06, 2002 NOV NEWA -A- AA 500MG;5MG N40477 001 NOV 06, 2002 NOV NEWA AMCINONIDE LOTION; TOPICAL -A- AMCINONIDE -A- AB ALTANA 0.1% N76329 001 NOV 06, 2002 NOV NEWA CYCLOCORT -D- + FUJISAWA...
Matching: depacon valproate Find similar documents More document info
100%
HTML
Efficacy Supplements Approved in Calendar Year 2002 (SE1-SE7 AND SE8s
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2002 (SE1 -SE7)* and EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2002 (SE8)* - GENERIC NAME APPLICANT NDA NUMBER SUPP TYPE SUPP NUMBER RECEIPT DATE APPROVAL DATE PRIORITY REVIEW- TOTAL APPROVAL TIME (MONTHS) INDICATION/DESCRIPTION ANASTROZOLE ASTRAZENECA 20-541 SE1 010 5-Mar-02 5-Sep-02 Y 6.0 Provides for the use of ARIMIDEX ...
author: Darlene Norris
Matching: depacon valproate Find similar documents More document info
100%
PDF
http://www.fda.gov/cder/foi/label/2002/20593se2006lbl.pdf
15 4) DEPACON VALPROATE ODIUM INJECTION Rx only BOX WARNING: HEPATOTOX C TY: HEPATIC FAILURE RESULTING IN FATALITIES HAS OCCURRED IN PATIENTS RECEIVING VALPROIC ACID AND ITS DERIVATIVES
WHEN DEPACON IS USED IN THIS PATIENT GROUP, IT SHOULD BE USED WITH EXTREME CAUTION AND AS A SOLE AGENT
TERATOGEN C TY: VALPROATE CAN PRODUCE TERATOGENIC EFFECTS SUCH AS...

Matching: depacon valproate Find similar documents More document info

100%
PDF
http://www.fda.gov/cder/foi/label/2002/20593se2006lbl.pdf page 2


Matching: depacon valproate Find similar documents More document info

100%
PDF
http://www.fda.gov/cder/foi/label/2002/20593se2006lbl.pdf page 1


Matching: depacon valproate Find similar documents More document info

100%
PDF
Information Page
1564) DEPACON O O VALPROATE SODIUM INJECTION Rx only BOX WARNING: HEPATOTOXICITY: HEPATIC FAILURE RESULTING IN FATALITIES HAS OCCURRED IN PATIENTS RECEIVING VALPROIC ACID AND ITS DERIVATIVES
NDA 20- 593/ S- 006 Approved Labeling Text dated January 23, 2002 Page 18 Adverse events reported by at least 0.5% of all subjects/ patients in clinical trials of DEPACON are...

author: Jackie Ware
Matching: depacon valproate Find similar documents More document info

100%
PDF
Information Page page 23


author: Jackie Ware
Matching: depacon valproate Find similar documents More document info

100%
PDF
Information Page page 16


author: Jackie Ware
Matching: depacon valproate Find similar documents More document info

100%
PDF
Information Page page 12


author: Jackie Ware
Matching: depacon valproate Find similar documents More document info

100%
PDF
Information Page page 8


author: Jackie Ware
Matching: depacon valproate Find similar documents More document info

100%
PDF
Information Page page 2


author: Jackie Ware
Matching: depacon valproate Find similar documents More document info

100%
PDF
Information Page page 1


author: Jackie Ware
Matching: depacon valproate Find similar documents More document info

100%
HTML
FDA Drug Approvals List June 2000
Active Ingredient(s): MIDAZOLAM HYDROCHLORIDE OTC/RX Status: RX Original Abbreviated Application # 075448 Approval Date: 19-JUN-00 Trade Name: ISOSORBIDE MONONITRATE Dosage Form: TABLET, EXTENDED RELEASE Applicant: ZENITH GOLDLINE PHARMACEUTICALS Active Ingredient(s): ISOSORBIDE MONONITRATE OTC/RX Status: RX Original Abbreviated Application # 075549 Approval Date: 13-JUN-00 Trade...
Matching: depacon valproate Find similar documents More document info
100%
PDF
http://www.fda.gov/cder/ogd/rld/18723s28.PDF
Steck: Please refer to the following supplemental new drug applications submitted under section 505( b) of the Federal Food, Drug, and Cosmetic Act for Depakote Tablets (divalproex sodium delayed release tablets), Depakote Sprinkle Capsules (divalproex sodium coated particles in capsules), Depacon Injection (valproate sodium injection), Depakene Capsules (valproic acid capsules...

Matching: depacon valproate Find similar documents More document info

100%
PDF
http://www.fda.gov/cder/ogd/rld/18082s23.PDF
Steck: Please refer to the following supplemental new drug applications submitted under section 505( b) of the Federal Food, Drug, and Cosmetic Act for Depakote Tablets (divalproex sodium delayed release tablets), Depakote Sprinkle Capsules (divalproex sodium coated particles in capsules), Depacon Injection (valproate sodium injection), Depakene Capsules (valproic acid capsules...

Matching: depacon valproate Find similar documents More document info

100%
HTML
DDPA June 1996
50-719 HELIDAC KIT PROCTOR GAMBLE PHARM BISMUTH SUBSALICYLATE 05-JUN-96 (TABLET, CHEWABLE; CINCINNATI, OH 262.4MG/TABLET CHEWABLE TABLET; 45241 METRONIDAZOLE CAPSULE) 250MG/TABLET TETRACYCLINE 500MG/CAPSULE (ANTIULCER) 20-593 DEPACON ABBOTT VALPROATE SODIUM 06-JUN-96 (INJECTABLE) ABBOTT PARK, IL EQ 100MG ACID/ML 60064 (ANTICONVULSANT) 20-441 PULMICORT-200 ASTRA BUDESONIDE...
Matching: depacon valproate Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.